Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 365)
Posted On: 05/19/2021 11:02:32 PM
Post# of 36568
Posted By: Buildit
1) Q for the group.

If there are currently 0 Class B shares outstanding, as the S1A says, how does this come into play (page 9):

"Our executive officers and directors have agreed with the underwriters not to sell, transfer or dispose of any shares of Class B Common Stock for 180 days following the effective date of the registration statement for this offering."

Maybe it's just a boiler plate statement, or maybe it means if an officer or director purchases shares after trading begins they can't sell them until the 180 day mark?


2) With regard to my statement earlier about Class A and Class B shares being equal, I did just read this statement:

"If we liquidate, dissolve or wind up, holders of the Class B Common Stock will have the right to receive $11.00 per share before any payment is made to the holders of our Class A Common Stock." Hopefully we don't go belly up, so this won't come into play!


3) Under Use of Proceeds, it shows Covid Vaccine Clinical Trials using $20MM+. I thought trials were being funded by our partners...













(1)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site